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Alexander Nowicki, Natalie Nowicki, Stella Nowicki, 
Alfred Samet, Michal Michalik, Roger Su, James K. Fortson 
and Bogdan Nowicki
Abstract
Chronic sinusitis leads to unresolved infection and inflammation resulting in tissue 
remodeling, then further propagates the vicious cycle of deterioration and dysfunc-
tion of the sinuses’ natural defense mechanisms, and yet another cycle of infection 
and mucosal injury. Antibiotic therapy targeting pathogens classically implicated in 
sinusitis could augment the risk of therapeutic failure through the natural selection of 
resistant and/or virulent pathogens, especially in the presence of Gram-negative E. coli. 
Our recent demonstration of highly pathogenic E. coli, detected through intraopera-
tive biopsy of sinus tissue, allowed the resolution of chronic sinusitis symptoms upon 
E. coli targeted therapy. The isolated E. coli carried three genes, each coding biofilm 
formation, which may, in part, account for the chronicity of E. coli sinusitis. We recom-
mend that, patients with chronic sinusitis be considered for intraoperative biopsy for 
unusual pathogens, therefore allowing targeted therapy. In the future, use of vaccines 
and biofilm inhibitors might be an effective therapeutic consideration.
Keywords: chronic sinusitis, rhinosinusitis, E. coli, biofilm, genotype, virulence 
factors, antibiotic treatment, antibiotic resistance, biopsy
1. Introduction
1.1 Is CRS directly caused by infectious agents?
Our current state of knowledge indicates that chronic rhinosinusitis (CRS) is not 
directly caused by infectious agents [1]. Instead, the current paradigm states that 
CRS is a spectrum of “self-perpetuating” non-infectious inflammatory processes. 
If this is the case, that would mean that repetitive, long term, systemic antibiotic 
therapy has little to no role in the treatment of CRS, except in the event of an acute 
exacerbation. Furthermore, this would suggest that clinical improvement of CRS 
would be more appropriately explained by the reduction of inflammatory injury as 
a whole, and only secondarily by the amelioration of bacterial load and the resultant 
removal of super-antigens.
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Albeit this working theory pivots upon a non-infectious etiology it does raise 
many concerns in the direction of microbiology. The most paramount of which is 
that the misappropriate, frequent, and long term use of antibiotics actually selects 
for a pathological microflora, composed of microorganisms resistant to antibiot-
ics, which may also form biofilms that may never be eradicated [1]. These biofilms 
may then act as the perfect stage for future acute exacerbations, functioning as a 
protective bunker for bacteria lying dormant within the film, and even create quasi-
resistant bacteria. For example, a naturally antibiotic-sensitive bacterium contained 
within a biofilm may be out of reach of the action of an antibiotic, rendering it 
resistant-in-vivo.
This idea is closely paralleled and supported by animal models of Pseudomonas-
biofilm formation within sinus mucosa; where, Pseudomonas-biofilm required 400 
times the concentration of tobramycin to be eradicated. Similarly, topical antibiotics 
are frequently ineffective at standard doses, which is often considered clinical proof 
of the non-bacterial etiology of CRS [2]. However, whether or not the proposed 
explanations are clinically valid for a non-bacterial mechanism of CRS remains 
a debatable issue and should be carefully evaluated in the context of published 
studies.
Now, we will review these questions in a step-by-step fashion: physiology, sinus 
microflora, and recent discoveries on the role of punch biopsy in CRS and its detec-
tion of deep-tissue sinus infection.
2. Is a healthy sinus cavity free of bacteria?
So, now the question is, is sterility synonymous with well-being? By using 
microbiome technology to detect difficult to culture bacteria, it was observed that 
bacteria are present in both healthy and diseased sinuses [3]. However, a pilot study 
on CRS patients actually discovered a significantly lower taxa of bacteria than their 
healthy control. So, at first glance it may look like the opposite, a lower number of 
bacteria is correlated with a higher likelihood of CRS. Does this point to a non-
infectious etiology, then?
Importantly, these microbiome studies did not only reveal a difference in abso-
lute number of bacteria, but in the content of the bacterial flora. Further analysis 
revealed that the bacterial taxa of the CRS patients was largely defined by relatively 
high numbers of unique single species, such as Corynebacterium tuberculostearicum, 
while microbiome analysis in the healthy control group showed a relative abun-
dance of Lactobacillus spp., Enterococcus spp., and Pediococcus spp., but what does all 
of this mean in practice? These findings suggest that the etiology of CRS may hinge 
upon balance and equilibrium, and not at all upon bacterial load.
To investigate this hypothesis further, a study was designed on a mouse model 
of inflammatory sinusitis. This study revealed something extremely interesting. 
Sinus infection by C. tuberculostearicum led to hyperplasia [3], but not by itself. This 
hyperplasia only occurred with the administration of antibiotics. It looks that the 
use of antibiotics backfired. Upon antibiotic treatment the commensal bacteria of 
the healthy sinus cavity were eliminated, selecting for an antibiotic resistant strain 
C. tuberculostearicum, which became opportunistically pathogenic without a com-
mensal microflora to police its growth. But what would happen if we rebalanced our 
flora? Could this process be reversed?
Interestingly enough, upon the addition of the Lactobacillus sakei the process 
reversed entirely, returning the sinus cavity to its natural state. The conclusion of 
this intriguing study was that antibiotic treatment of acute rhinosinusitis may be 
a “Catch-22”, and although it may rid the body of the archetypal bacteria of acute 
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sinusitis, it may contribute to the future development of persistent sinusitis and/
or CRS. These findings spark many questions and begin to steer the medical mind 
toward similar situations within different specialties.
Taking these discoveries of bacterial imbalance into consideration, it may be 
appropriate to draw analogies across specialties, and explore the realm of micro-
biotic imbalance in the upper respiratory tract as it relates to the female urogenital 
tract. We may be able to draw important conclusions in the pathogenesis of floral-
imbalance-induced-CRS through the data analysis of microbiome studies in bacte-
rial vaginosis (BV). BV is an infection in which anaerobic bacteria overgrow vaginal 
mucosa as a direct result of the, often inadvertent, elimination of Lactobacillus 
species [4]. These species naturally secret bactericidal H2O2 that kills anaerobic 
species—protecting the delicate membranes of the vaginal mucosa. Just as CRS, 
BV is frequently a recurrent process. However, a very simple single treatment with 
Metronidazole and/or recolonization with Lactobacillus often restores the health of 
mucosal membranes. It may be an oversimplification of a complex disease state, but 
the possibility of a similar etiology and therefore similar non-invasive cost-effective 
treatment is tantalizing.
2.1 Alternative thesis: CRS involves direct bacterial infection
As much evidence as there may be for the noninfectious hypothesis of CRS, 
there is just as much supporting the opposite. So where does the truth lie? As with 
most things in life, most likely somewhere in the middle. Either way, here we will 
explore the possibility of infectious CRS, and some of the most recent discoveries 
and theories behind it.
The noninfectious hypothesis of CRS is certainly a tantalizing one, but it is 
strongly challenged by the alternative hypothesis [5]. The authors of this chapter 
tend to lean toward the more active process of infection as the most common 
etiology, and we propose that the predominant progression of CRS directly involves 
bacterial infection. Furthermore, we believe that most of the theories and concepts 
pointing toward a noninfectious etiology, have been improperly evaluated and 
interpreted, and when reanalyzed tend to support an infectious cause of CRS.
Many parallels can be drawn between the two main arguments, one of which is 
the selection of microflora and or pathogens by inadequate or improper antimicro-
bial treatment. Some pathogens, such as E. coli, are able to both actively and pas-
sively elude destruction and clearance through multiple mechanisms, and current 
studies are pointing toward the fact that we as clinicians are inadvertently selecting 
for them. Through mechanisms similar to those described in the previous sections, 
incomplete treatment of bacterial sinusitis looks to be inducing the escape of such 
organisms from the reach of the immune system as a whole, as well as antibiotics 
specifically, by driving these microorganisms into our body’s white cells or deep 
within the sinus mucosa. Simultaneously, the resultant disruption of the commen-
sal bacterial community and mucosal integrity of the sinus leads to the formation 
of biofilm, which in our opinion is both a strong supplementary contributor and a 
direct cause of subacute and chronic infectious processes.
As discussed previously, a weakened microflora may contribute to the dysfunc-
tion of the sinus mucosa and disruption of the general local immune state. This, in 
combination with a slew of other complex factors, creates the perfect platform for 
the formation of a biofilm. Once formed, biofilm contributes to the failure of the 
antibiotic treatment by preventing any significant antibiotic penetration. Bacteria 
hiding within the structure of the film, become effectively invulnerable, when in 
any other situation they would be easily eliminated. As an added layer to the issue, 
superficial swab and culture of the mucosal surface may be completely misleading. 
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A positive bacterial culture of the biofilm showing in vitro antibiotic sensitivity 
may misdirect therapy entirely. Although you’ve confirmed in vitro effectiveness of 
therapy in regard to your surface culture, the chosen antimicrobial will most likely 
miss any pathogen lying deep within the film, interstitium, or intracellular space, 
rendering the chosen treatment clinically moot when used in-vivo.
Now put yourself in the shoes of the clinician. You’ve swabbed properly and 
sent for culture and sensitivity, then treated accordingly, but there is no clinical 
improvement in your patient’s state of health. So, what do you do next? What 
conclusions may you draw? Such a cycle of negligible response to antibiotic therapy 
may inappropriately perpetuate the idea of pathogen independent CRS, when in 
reality it should raise questions of drug choice, administration, and adjunct therapy.
This thought process brings one particular example to mind and into question. 
Recently Antunes et al. showed that a Pseudomonas containing biofilm required 400 
times the concentration of tobramycin to be eradicated than its control counterpart. 
While this finding became a warning, heeded by many, against the “ineffective” 
antibiotic treatment of biofilm, and even further, considered by some as the dis-
proval of a bacterial origin of CRS, this may be a grave misunderstanding. Looking 
back to our foundations in pharmacology we must remember that many antibiotics 
have near-no activity on intracellular pathogens hiding within white or epithelial 
cells [6]. A fantastic real-world example of this being the aminoglycosides, like 
tobramycin, in particular.
In the world of microbiology the classic model for establishing intracellular 
infection in vitro is achieved by introducing an aminoglycoside to the infected 
epithelial cell culture. Once introduced the aminoglycoside does in fact eliminate 
the extracellular bacteria, however counterintuitively it actually positively selects 
for the intracellular pathogens. This pharmacological model is well established in 
many fields of microbiology and Infectious Disease research, often exploited in 
many classic experimental algorithms, across many specialties—except, it seems, 
for those in the area of ENT and CRS [6]. Such an oversight may have immensely 
detrimental effects on the validity of conclusions drawn from an otherwise 
extremely important finding.
The current paradigm of thought, that chronic rhinosinusitis has no direct 
infectious etiology, is further challenged by the clinical efficacy of treatment with 
Mupirocin lavage in CRS patients who had positive endoscopically guided cultures 
for Staphylococcus aureus [7]. In one recent investigation of CRS, 15 of 16 patients 
treated with Mupirocin-saline nasal irrigation, twice daily for 3 weeks, saw signifi-
cant clinical improvement followed by a negative repeat culture for S. aureus after 
treatment. A follow-up double-blinded, placebo-controlled, study on 22 patients 
with CRS non-responsive to surgery demonstrated infection clearance in 8 of 9 
patients after 1 month of mupirocin treatment [8]. Although the clinical improve-
ment could be explained by the resolution of an acute exacerbation or the elimina-
tion of Staphylococcus super-antigens, these studies clearly challenge the current 
dogma of noninfectious CRS, and furthermore may directly support a pathogenic 
etiology of chronic sinusitis.
3. Finding E. coli in patients chronically ill with sinusitis
There is much left to understand and discover about the pathogenesis of CRS, 
from both the infectious and non-infectious standpoints, and it will be many 
years before we have a full grasp on the matter, if ever. In the meantime, many 
groups are publishing some interesting studies with very exciting results, and 
conclusions.
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Recently, we have reported on the importance of proper biopsy in chronic sinus-
itis, and how such data may influence treatment and outcomes [5]. Interestingly, 
the predominance of specific pathogens differs in congruence with the method 
of sample collection. For instance, with swab and culture bacterial growth is 
most commonly dominated by the classic Gram-positives implicated in sinusitis. 
However, when samples are collected intraoperatively, by punch biopsy, the script 
is flipped and a predominance of Gram-negatives, including E. coli, is found [9, 10]. 
Therefore, logic dictates that if antibiotic therapy targets only the classic culprits 
of sinusitis, with Gram-negatives present, we may be achieving an incomplete or 
even inappropriate eradication of microflora and pathogens. This could explain and 
contribute to therapeutic failure in recurrent sinusitis, its transition into chronicity, 
and its interpretation as noninfectious [11–19].
In general, the presence of nonclassical pathogens such as Gram-negatives, 
namely E. coli, has been poorly documented. However, more and more groups are 
finding E. coli in patients chronically ill with sinusitis, and the question remains, 
“Are these contaminants, or are they true pathogens?”. By definition if the latter 
is true, and these isolated E. coli are pathogenic, there should be evidence of their 
ability to produce disease, through the demonstration of various virulence factors 
[20–22]. Alternatively, if they are non-pathogenic and represent random contami-
nation or commensal properties then there should be no evidence of genetic mark-
ers of virulence. So far, the nature of E. coli virulence and potential for cause of CRS 
remains largely unknown [23–26]; and while numerous studies have explored the 
role of virulence genes in chronic and recurrent GI and Urinary Tract infections, no 
such data has been available in regard to chronic sinusitis, until recently [5, 23–25].
We recently published the first report demonstrating an association between a 
highly pathogenic E. coli, chronic sinusitis, and the resolution of symptoms upon 
E. coli targeted therapy [5]. Our findings support the theory that a non-classical 
pathogen may lurk below the radar in non-pharmacologically-responsive CRS 
and would only be detected by the use of proper techniques. When we performed 
intraoperative biopsy and culture on our chronic sinusitis patients, followed by 
genetic analysis of virulence factors, we found the presence of a clearly non-random 
pathogenic E. coli. These E. coli carried genes encoding multiple virulence factors, 
granting them the ability to produce biofilm. Upon catering our antibiotic therapy 
to each patient’s biopsy and culture, we were able to obtain long term resolution of 
symptoms. These results, as a whole, lead us to believe that there very well may be 
genetic uniformity amongst E. coli isolated from patients suffering from CRS. These 
are not randomly occurring colonizers, or opportunistic colonizers.
3.1 Genetic analysis discover highly pathogenic E. coli in CRS
Generally, E. coli can be grouped genetically. Commonly, commensal E. coli are 
placed in phylogenetic groups A or B1, while pathogenic isolates are grouped in B2 
or D [27, 28]. Upon in-depth genetic analysis of these patients, we found that 77% 
of isolated E. coli belonged to the pathogenic phylogenetic group B2, while only 
23% belonged to the commensal B1 group [5]. This is concerning, not only due to 
shear pathogenicity, but the numerous dangerous traits associated with the bacteria 
in group B2. E. coli within this group are commonly capable of iron acquisition, 
granting them the ability to invade cells and multiply intracellularly and even 
within the blood stream. This makes members of the phylogenetic group B2 par-
ticularly toxic—contributing greatly to the inflammatory process and tissue injury 
of chronic infection.
Diving deeper, we find that these E. coli share many attributes with extrain-
testinal-pathogenic-E. coli. However, other features suggest that they might 
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be specifically pathogenic to sinus tissue [29, 30]. One example of this tissue 
specificity is the sfa adhesin gene, normally associated with meningitis [31]. It 
is no stretch of the imagination to think that two anatomical structures, in such 
close proximity as the sinuses and the meninges, may be invaded through similar 
cytophysiological pathways. Especially by multiple bacteria with a generally 
enigmatic local affinity, whom happen to share virulence factors. This association 
needs to be explored further, but for now it is exciting to think that we may be 
able to better explain local affinity (tropism) to the head and neck through such 
mechanisms.
Other highlights of this genetic analysis include the finding of both the hlyA and 
usp genes. These genes encode for the formation of bacterial toxins and are only 
present in highly virulent bacterial strains. In this patient group, they were present 
in over 70% of the E. coli isolates. By the other side of the same token, isolates were 
found to lack dra/afa adhesins, which are implicated in chronic and recurrent UTI 
and gestational pyelonephritis. Such a bold distinction may further support the idea 
that these isolates represent a novel subset of E. coli, with a unique genome, and 
possibly even tropism for the mucosa of the paranasal sinuses [32].
Unexpectedly, there were three genes that were found in 100% of isolated E. 
coli from our patients. These genes were agn43, fimG/H, and fyuA [33–36]. All of 
which are associated with UTI, and play a role in biofilm formation: agn43 assists 
in E. coli-E. coli self-adhesion, fimG/H codes for type 1 fimbriae allowing for E. coli 
to aggregate and adhere to mannose receptors on mucosal membranes, while fyuA 
assists in iron scavenging and is often implicated in septicemia.
Possibly most shocking of all is that, when analyzed via a pseudo-phylogenetic 
tree, these genes had closely associated genetic loci, which signifies a very probable 
cooperation amongst them. This raises a very concerning question. Could these 
three genes, working together, code for some sort of “super biofilm”? This could 
explain how and why so many mono-therapies and empiric treatments fail to yield 
any improvement in patients who suffer from CRS. A biofilm of this nature would 
in essence be both a defensive and offensive fortification for the pathogen. A sort 
of moated fortress with large watch towers, never allowing antibiotics or the host 
immune system to penetrate it, creating an ideal environment for lingering infec-
tion and chronic inflammation.
The resolution of CRS—following FESS, intra-operative biopsy, and antibiotic 
therapy targeted toward the resultant culture and sensitivity—is highly sugges-
tive of E. coli’s strong contribution to the disease state of this patient population. 
Undoubtedly, this all hinges upon the genetic makeup of these bacteria, and the fact 
that their genetic code is set for pathogenesis by carrying the information necessary 
to express virulence factors, including the production of biofilm [37, 38]. Further 
deductive reasoning leads us to believe that, E. coli is a generally undermined and 
undetected etiologic factor of CRS and a major contributor of inflammation in 
these patients. Whether or not the presence of biofilm producing E. coli is directly 
responsible for the poor therapeutic response, after FESS alone, will continue to be 
explored in more detail [39–42].
As with all, there are limitations to this study that should be recognized. For 
example, the present investigation was a study of healthcare-seeking adults; only 
including those that were E. coli positive, raising a very important question. To 
what extent do these results apply to the general population? Next, due to the 
resolution of symptoms and subsequently negative cultures, along with consider-
ation for cost and patient comfort, we did not perform a follow-up punch biopsy 
and analysis.
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4. Future studies
Future studies should investigate the role of important factors in human health, 
such as the effects of hormones, like estrogen and progesterone, on chronic sinusitis 
[43, 44]. Which are known to control the immune system. We must also further 
explore the effects of obesity and diabetes mellitus on the risk of infection, as well as 
the relation of anatomical structure and function on the role of bacterial coloniza-
tion. All of these factors change the expression of mucosal receptors, which is often 
exploited by various bacterial species, easing colonization and/or infection [32, 45].
In regard to the possibility of hormonal control of the immune system of the 
upper respiratory tract, we speculate that the head and neck may be analogous to the 
female urogenital tract. Wherein sensitivity to infection rises during the secretory 
and proliferative phases of the menstrual cycle [44]. Exploring further in this direc-
tion, the anatomical structure of the upper respiratory system appears to resemble 
the urogenital tract in many ways. Within the urinary tract an ascending infection 
begins with the colonization of vaginal introitus, before migrating proximally [21]. 
Genital colonization with E. coli may progress to infection of the urethra, which then 
ascends to the bladder, and further up to the kidneys via the ureters. This is made 
possible through the exploitation of tissue specific receptors to which bacteria anchor 
via specialized adherence structures called fimbriae [46, 47]. This process of bacterial 
migration results in acute pyelonephritis, often followed by chronic kidney infection 
with even further spread to the blood stream and resultant urosepticemia [48–50]. 
Similarly, we implore the medical community to consider the oropharynx, nasal 
cavities and paranasal sinuses as another anatomical system conducive to similar 
ascending infections [21, 45]. Beginning with the colonization of the oral and nasal 
cavities, bacteria may migrate “upstream” to the maxillary and then frontal sinuses, 
as well as others along the way via similar receptor-ligand interaction. All of which 
may be complicated by anatomical variation, anomaly, and pathology, ranging from 
nasal polyps and turbinate hypertrophy to choanal atresia and structural issues of 
the sort. These problems may be caused by everything from allergy to genetic muta-
tion—resulting in a slew of aggravating factors, expression of specialized epithelial 
cell types, and tissue receptors—all contributing to the risk of chronic rhinosinusitis.
5. Considerations and conclusions
All things considered, chronic sinusitis remains a bit of an enigma. However, the 
more we explore the better we will be able to understand the complex multifactorial 
etiology that’s sure to be lying below the surface. That being said, we’ve learned and 
discovered so much as a medical community in recent years, we believe there is no 
better time than now to begin making the most of it.
Keeping in mind the most recent publications and studies, we urge physicians 
to consider intraoperative punch biopsy on all of their chronic sinusitis patients 
[5]. Biopsied samples should be homogenized, and host cells should be exposed to 
membrane destabilizing buffers, lysing them and releasing trapped intracellular 
bacteria, allowing for the most thorough culture and analysis. Considering that a 
direct culture of the sample on solid media may not always be fruitful, we recom-
mend the use of liquid media which may better allow the growth and detection 
of bacteria, even at low numbers. Next, cultures should be tested individually for 
antibiotic sensitivity and a personalized therapy should be prescribed to each indi-
vidual patient. Finally, we also urge you to consider sending bacterial isolates for 
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provided the original work is properly cited. 
genotyping [35, 48, 51–57]. Through doing so we can finally stop asking of ourselves 
if we’re fighting the right bug and know for certain that if it expresses virulence it is 
part of the problem.
We believe that through the use of these methods we may be able to better dif-
ferentiate between specific etiologies of CRS within our patients, and through doing 
so we hope that we can avoid inappropriate antibiotic use, repeat surgeries, and 
prolonged treatment. Giving our patients their health and quality of life back faster 
and more effectively than ever.
In conclusion, we hope that personalized medicine may one day overshadow empiric 
treatment in chronic sinusitis, and all of our patients will be catered to with the utmost 
efficiency. With further testing and experimentation, we may be able to someday use 
vaccines or bacterial adhesion blockers to augment our therapies [30, 58]. Using geno-
typing to pick and choose what’s best for our patients, we may be able to target specific 
virulence factors that allow such abilities as iron binding or cellular adherence, effec-
tively rendering those bacterial invaders non-pathogenic. Through interdisciplinary 
exploration we may be able to adopt and adapt what other specialties have learned and 
use it to restore mucosal and micro-floral balance, and band together to fight bacteria 
and biofilm together as a medical community.
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